NCT03099564 2023-02-06
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Hoosier Cancer Research Network
Phase EARLY_PHASE1 Unknown
Clinical Trials
9 trialsNCT05154812 2021-12-13
Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05152498 2021-12-09
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05088733 2021-11-19
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)
Beijing Ditan Hospital
Phase EARLY_PHASE1 Unknown
NCT05007587 2021-08-16
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
Zhejiang Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT04518774 2020-08-19
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
Beijing 302 Hospital
Phase EARLY_PHASE1 Unknown
NCT03965546 2019-08-08
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Unknown
NCT04048317 2019-08-07
Effectiveness of Drug Eluting TACE in Primary HCC
Assiut University
Phase EARLY_PHASE1 Unknown
NCT03672305 2018-09-18
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1 Unknown